Cargando…

Multidrug-resistant tuberculosis infection and disease in children: a review of new and repurposed drugs

The World Health Organization estimates that 10 million new cases of tuberculosis (TB) occurred worldwide in 2017, of which 600,000 were rifampicin or multidrug-resistant (RR/MDR) TB. Modelling estimates suggest that 32,000 new cases of MDR-TB occur in children annually, but only a fraction of these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huynh, Julie, Marais, Ben J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643170/ https://www.ncbi.nlm.nih.gov/pubmed/31367376 http://dx.doi.org/10.1177/2049936119864737

Ejemplares similares

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges
por: Tadolini, Marina, et al.
Publicado: (2016)

Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria
por: Liu, Yuan, et al.
Publicado: (2021)

1380. Safety of Repurposed Drugs for Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: An Analysis of Adverse Events Reported in the Literature
por: Stone, Heather, et al.
Publicado: (2019)

New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline
por: Leibert, Eric, et al.
Publicado: (2014)

Niclosamide as a Repurposing Drug against Corynebacterium striatum Multidrug-Resistant Infections
por: Folliero, Veronica, et al.
Publicado: (2022)

Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections
por: Thangamani, Shankar, et al.
Publicado: (2015)

Repurposing Eltrombopag for Multidrug Resistant Staphylococcus aureus Infections
por: Lee, Hyunjung, et al.
Publicado: (2021)

Drug Repurposing of the Anthelmintic Niclosamide to Treat Multidrug-Resistant Leukemia
por: Hamdoun, Sami, et al.
Publicado: (2017)

Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid
por: Pecora, Francesco, et al.
Publicado: (2021)

Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis
por: Sharma, Divakar, et al.
Publicado: (2017)

New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for Clinicians
por: Aguilar Diaz, Jessica M, et al.
Publicado: (2023)

Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi
por: Peyclit, Lucie, et al.
Publicado: (2021)

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Sotgiu, Giovanni, et al.
Publicado: (2016)

The need to accelerate access to new drugs for multidrug-resistant tuberculosis
por: Cox, Helen S, et al.
Publicado: (2015)

Current therapies for the treatment of multidrug-resistant tuberculosis in children in India
por: Mukherjee, Aparna, et al.
Publicado: (2017)

Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
por: Miró-Canturri, Andrea, et al.
Publicado: (2021)

Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
por: Miró-Canturri, Andrea, et al.
Publicado: (2021)

Repurposing Cefazolin-Avibactam for the Treatment of Drug Resistant Mycobacterium tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2021)

Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant Acinetobacter baumannii
por: Cheng, Yu-Shan, et al.
Publicado: (2019)

Global Introduction of New Multidrug-Resistant Tuberculosis Drugs—Balancing Regulation with Urgent Patient Needs
por: Sullivan, Timothy, et al.
Publicado: (2016)

Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies
por: Prasad, R.
Publicado: (2012)

Drug Repurposing Approaches towards Defeating Multidrug-Resistant Gram-Negative Pathogens: Novel Polymyxin/Non-Antibiotic Combinations
por: Koh Jing Jie, Augustine, et al.
Publicado: (2022)

In vitro Activity of Repurposed Nitroxoline Against Clinically Isolated Mycobacteria Including Multidrug-Resistant Mycobacterium tuberculosis
por: Hoffmann, Ada Marie, et al.
Publicado: (2022)

Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis
por: Byrne, Anthony L., et al.
Publicado: (2017)

Bedaquiline: A new drug approved for treatment of multidrug-resistant tuberculosis
por: Deoghare, Shashank
Publicado: (2013)

Novel Treatments against Mycobacterium tuberculosis Based on Drug Repurposing
por: Mourenza, Álvaro, et al.
Publicado: (2020)

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
por: Eker, Barbara, et al.
Publicado: (2008)

Review on Bovine Tuberculosis: An Emerging Disease Associated with Multidrug-Resistant Mycobacterium Species
por: Borham, Mohamed, et al.
Publicado: (2022)

High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?
por: Ragonnet, Romain, et al.
Publicado: (2017)

Repurposing Immunomodulatory Drugs to Combat Tuberculosis
por: Fatima, Samreen, et al.
Publicado: (2021)

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Migliori, Giovanni Battista, et al.
Publicado: (2017)

Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
por: Oehadian, Amaylia, et al.
Publicado: (2022)

The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review
por: Lee, Chiyun, et al.
Publicado: (2021)

Analysis of Factors Influencing Multidrug-Resistant Tuberculosis and Validation of Whole-Genome Sequencing in Children with Drug-Resistant Tuberculosis
por: Zhang, Ying, et al.
Publicado: (2021)

Multidrug and extensively drug-resistant tuberculosis from a general practice perspective
por: Yashodhara, BM, et al.
Publicado: (2010)

A new oligonucleotide array for the detection of multidrug and extensively drug-resistance tuberculosis
por: Chen, Ching-Yu, et al.
Publicado: (2019)

Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing
por: Bahmad, Hisham F., et al.
Publicado: (2022)

Drug resistance detection and mutation patterns of multidrug resistant tuberculosis strains from children in Delhi
por: Arora, Jyoti, et al.
Publicado: (2017)

A review of computational drug repurposing
por: Park, Kyungsoo
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_745ndlfdls73e8lf8u3smd5329